---
title: "Qube Research & Technologies discloses net short position in Cellectis shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294219844.md"
description: "Qube Research & Technologies has disclosed a 0.5% net short position in Cellectis shares, as reported in an AMF filing."
datetime: "2026-07-29T13:58:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294219844.md)
  - [en](https://longbridge.com/en/news/294219844.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294219844.md)
generator: "portal-rs"
---

# Qube Research & Technologies discloses net short position in Cellectis shares

-   Qube Research & Technologies disclosed a 0.5% net short position in Cellectis shares, according to an AMF filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectis SA published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)

## Related News & Research

- [Cellectis publishes corporate presentation on allogeneic CAR-T pipeline, TALEN gene-editing platform](https://longbridge.com/en/news/295217037.md)
- [Cellectis expects interim readout in Q4 2026 from pivotal BALLI-01 trial of lasme-cel in relapsed/refractory B-cell ALL](https://longbridge.com/en/news/295149883.md)
- [Tyga is Hollywood’s latest AI optimist](https://longbridge.com/en/news/296029242.md)
- [Duos Technologies names Dipan Patel chief operating officer](https://longbridge.com/en/news/296266057.md)
- [Rockwool announces availability of 2026 half-year report](https://longbridge.com/en/news/296326112.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**